| Literature DB >> 23772351 |
Stuart S Dunn1, James D Byrne, Jillian L Perry, Kai Chen, Joseph M Desimone.
Abstract
The complexity of tumor biology warrants tailored drug delivery for overcoming the major challenges faced by cancer therapies. The versatility of the PRINT® (Particle Replication In Non-wetting Templates) process has enabled the preparation of shape- and size-specific particles with a wide range of chemical compositions and therapeutic cargos. Different particle matrices and drugs may be combined in a plug-and-play approach, such that physico-chemical characteristics of delivery vectors may be optimized for biocompatibility, cargo stability and release, circulation half-life, and efficacy. Thus, the engineering of particles for cancer therapy with specific biophysical behaviors and cellular responses has been demonstrated via the PRINT process.Entities:
Keywords: PRINT; cancer; drug delivery; medicine; nanoparticle; soft lithography
Year: 2013 PMID: 23772351 PMCID: PMC3680140 DOI: 10.1021/mz400116a
Source DB: PubMed Journal: ACS Macro Lett Impact factor: 6.903